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Introduction
Cerebral amyloid angiopathy (CAA) is characterized by 
β-amyloid deposition in the media and adventitia of small 
and medium vessels of the cerebral cortex, subcortex, and 
leptomeninges [1-3]. CAA is a major cause of spontaneous 
lobar intracerebral hemorrhage (ICH) in normotensive 
elderly [1-3]. Hereditary and sporadic forms may occur, and 
the latter increases with age [2, 4-8]. ICH can take the form 
of macro-hematoma (MH) or micro-bleedings (MB) with 
various clinical presentations [9]. CAA frequently involves 
the occipital lobes, followed by the frontal, temporal, or 
parietal lobes, respectively [5, 9], but involvement of the 
cerebellum in CAA remains uncertain [5, 10]. Micro- 
or macro-hemorrhages in the deep brain structures or 
brainstem are an exclusion criterion for CAA. 
The objectives of the current study were to assess the 
presence of cerebellar involvement in patients with CAA 
according to the modified Boston criteria [5] and to study 
the changes in the white matter. 
Patients with spontaneous ICH were collected in two 
academic tertiary care centers and were included in a 
DOI: 10.5281/zenodo.3958435
UDC: 616.831-005.1+616.831.37+616.831.71
White matter hyper-intensity patterns in patients with amyloid angiopathy 
and cerebellum involvement
*1Pavel gavriliuc, 1Mihail gavriliuc, 2Stanislav groppa, 3Ronen Leker
1Department of Neurology No 1, 2Department of Neurology No 2 
Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova
3 Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Authors’ ORCID iDs, academic degrees and contribution are available at the end of the article
*Corresponding author: gavriliucpavel@gmail.com 
Manuscript received July 20, 2020; revised manuscript August 14, 2020; published online August 26, 2020
Abstract
Background: Pathological changes in the cerebral white matter can be determined both in small vessel disease and in cerebral amyloid angiopathy. The 
pattern of involvement may be different depending on the etiology and severity of the process. Objective of the study: Determination and analysis of the 
pattern of cerebral white matter changes in patients with amyloid angiopathy and involvement of the cerebellum.
Material and methods: Patients with intracerebral hemorrhages who were examined by magnetic resonance imaging were prospectively analyzed. Patients 
were diagnosed with cerebral amyloid angiopathy (CAA) according to Boston criteria. Changes in white matter were interpreted using the Fazekas scale 
and compared for patients with CAA and patients with CAA and cerebellar involvement. Of the 614 patients with intracerebral hemorrhage, 96 were 
examined by cerebral magnetic resonance imaging. Of these, 41 patients were diagnosed with amyloid angiopathy, 19 patients with possible amyloid 
angiopathy, 21 patients – probable and 1 case with defined amyloid angiopathy.
Results:  Cerebellar involvement was determined in 34% (14/41) of cases. Severe changes in white matter (Fazekas 2-3) were seen in patients with cerebellar 
involvement (12/14; 86% versus 8/27 and 30% p = 0.002). 
Conclusions: Involvement of the white matter in the pathological process is more significant in patients with amyloid angiopathy and the involvement of the 
cerebellum, even after adjusting for risk factors. Patients with cerebellar haemorrhage and severe white matter should be screened for amyloid angiopathy. 
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continuous database. The institutional IRB (Hadassah 
Medical Organization) approved the anonymous collection 
of data in this database and waived the need for informed 
consent. 
For the current analysis, we retroactively analyzed the 
data accumulated in the period 2009-2015. The diagnosis of 
spontaneous ICH was confirmed in all patients using non-
contrast computed tomography (CT). Patients with ICH 
secondary to trauma, vascular malformations, or tumors 
were excluded.
Material and methods
All 614 included patients underwent a standardized MRI 
protocol that included susceptibility weighted imaging or T2 
star imaging (SWI or T2 * respectively) as soon as possible 
after the hemorrhage. Recommendations for performing 
post-ICH MRI were left to the discretion of participating 
neurologists and were based on clinical suspicion of CAA 
or atypical presentation or localization of the bleeding on 
CT. From the group of patients who had MRI, we identified 
patients who met the diagnostic criteria for CAA, according 
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to the modified Boston criteria [5]. Patients with non-lobar 
ICH and systolic blood pressure over 150 mmHg were 
considered to have a hypertensive ICH. 
In patients who have undergone surgical procedures to 
remove the hematoma or decompressive craniectomy, the 
biopsy material has been studied for the presence of vascular 
amyloid deposits. Hematoma types, location and volumes 
were accumulated along with the vascular risk factor being 
noted. Bleedings were classified as MH or MB [5, 14] by 
experienced vascular neurologists and the absolute number 
of MB in the cerebral cortex were counted. The SWI or 
T2 * sequences were used to identify MB, while the other 
sequences were used to exclude MB mimicry, according to 
STRIVE criteria [15]. The presence of superficial cortical 
siderosis (CSS) has been documented and CSS has been 
classified as disseminated if it involved more than three 
grooves according to current recommendations [16-18]. 
Hyperintensities of deep white matter were measured on T2 
FLAIR according to STRIVE methods [15] and according 
to the Fazekas scale [19] (0 – none, 1 – dotted scattered, 2 – 
starting to be confluent and 3 – confluent) and dichotomized 
in severe (grade 2-3) or non-severe (grade 1-2).
Patients with CAA and cerebellar involvement were 
compared to patients with CAA without any cerebellar 
involvement. Cerebellar MB locations were studied and 
divided into superficial cortical versus deep, involving the 
nuclei [11, 20].
Neurological deficit was analyzed using the National 
Institute of Health Stroke Scale (NIHSS) at admission and 
discharge. Disability was studied with the modified Rankin 
scale (mRS) at discharge and day 90 post-ICH.
Statistical analysis was performed using SPSS software. 
The Student’s t-test was used to compare continuous 
variables and the chi-square test was used to compare 
nonparametric variables.
A multivariate regression analysis model was used to 
determine the factors that are associated with cerebellar 
involvement in patients with CAA. This model controlled 
for age, the severity of superficial siderosis, the existence of 
previous of ICH, the severity of the stroke at presentation, 
the volume of ICH, and the number of cortical micro-
hemorrhages counted.
Results
Overall, 614 patients with spontaneous ICH were 
included in our database (343 at one center and 241 at the 
other) and 85 (54 and 31, respectively) had a post-ICH 
MRI (14%). Of the 85 patients, 41 (48%) were diagnosed 
with CAA according to the modified Boston criteria [5] (19 
possible CAAs, 21 probable CAAs, and 1 defined CAA).
MRI patients were significantly younger (67.3 ± 12.2 
versus 72.4 ± 12.9; p = 0.005) and had significantly lower 
hemorrhage volumes (13.2  ±  20.9 vs. 36 .0 ± 57.2 cc; p 
= 0.003) compared to non-NMR group. Hypertension was 
significantly more common in patients who did not have 
MRI (67% versus 13%; p = 0.034), but other risk factors did 
not differ between groups.
In the total group of 614 patients, 64 (10%) presented 
with cerebellar MH, and 10 of them had MRI. Most of 
the 54 patients who presented with cerebellar MH who 
did not have an MRI (95% and 72% of the patients in the 
participating centers) had hypertensive ICH.
In the CAA-related hemorrhage group, cerebellar 
participation was present in 34% (14 of 41 patients). Most 
cerebellar lesions were MB (fig. 1) and most patients had 
multiple cerebellar lesions (mean 8.4 ± 13.3). Cerebellar MB 
was more frequently superficial (11/14 patients involved 
superficial cerebellar, 2/14 had deep cerebral MB and 1/14 
combined deep and superficial MB). A more severe degree 
of white matter hyperintensity (Fazekas 2–3) was more 
common in patients with cerebellar involvement (12/14; 
86% vs. 8/27; 30% p = 0.002).
Clinical variables including age, sex, risk factor profile, 
stroke severity, 90-day mRS scores, or survival were not 
different between CAA patients with and without cerebellar 
involvement (tab. 1).
Patients with CAA-related cerebellar involvement had a 
significantly higher number of lobular cortical MB compared 
Table 1








rhage (n = 
14)
P value
Age (mean ± SD) 70.5 ± 9.4 69.8 ± 8.2 0.82
Gender male (%) 13 (48%) 7 (50%) 0.910
Hypertension (%) 14 (52%) 8 (57%) 0.747
Diabetes (%) 3 (11%) 4 (29%) 0.159
Previous stroke (%) 3 (11%) 4 (29%) 0.159
Previous ICH (%) 3 (11%) 3 (21%) 0.375
Smoking (%) 3 (11%) 2 (14%) 0.768
Family history of ICH (%) 0 (0) 1 (7%) 0.160
Vitamin K antagonists (%) 2 (7%) 2 (14%) 0.482
Antiplatelet (%) 10 (37%) 8 (57%) 0.219
NOACs (%) 0 (0) 1 (7%) 0.457
History of dementia (%) 1 (7%) 3 (21%) 0.070
Hematoma size (ml mean 
± SD)
26 ± 29.5 17.3 ± 21.1 0.315
Ventricular extension (%) 1 (7) 0 (0) 0.457
Spot sign (%) 1 (7) 0 (0) 0.248
Admission NIHSS (mean 
± SD)
5.4 ± 5.5 4.0 ± 4.0 0.418
Total cortical microbleeds 
(mean ± SD)
2.8 ± 8.5 37.9 ± 39.6 < 0.00001
Confluent white matter 
hyperintensities (%)
8 (30) 12 (86) 0.002
Disseminated cortical 
superficial siderosis (%)
1 (3.7) 3 (21.4) 0.107
Modified Rankin  
score≤2 at day 90 (%)
13 (48) 6 (43) 0.747
Mortality (%) 2 (7) 0 (0) 0.296
ICH – Intracerebral hemorrhage, NOAC – Non-Vitamin K 
oral anticoagulants, NIHSS – National Institute of Health 
Stroke Scale. *Fazekas score 2–3.
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to patients without cerebellar involvement (37.8 ± 39.5 vs. 
2.8 ± 8.5; p <0.00001). CSS was present in 11 patients who 
had MRI and was classified as disseminated in 3. However, 
the absolute combined number of macro-hemorrhages (old 
+ new) or the presence of disseminated CSS (> 3 grooves) 
did not differ significantly (7.3 vs. 2.4%; p = 0.07).
In the multivariate analysis that controls age, stroke 
severity, previous ICH episodes, number of micro-bleeds, 
age, and severity of superficial siderosis, the only variable 
that was significantly correlated with cerebellar involvement 
in CAA patients was the number of cortical hemorrhages 
(OR 1.045, 95% CI 1.005-11.087) (tab. 2). Interestingly, the 
severity of stroke was inversely correlated with cerebellar 
involvement in patients with CAA (OR 0.814 95% CI 0.664–
0.997).
Table 2
Multivariate analysis for cerebellar CAA presence
Variable OR P 95% C.I.
Age (yr) 1.018 0.604 0.952 - 1.089
Previous ICH 1.729 0.564 0.269 - 11.135
Hematoma size (ml) 1.016 0.353 0.982 - 1.051
Degree of superficial siderosis 1.518 0.052 0.997 - 2.311
Number of MB 1.045 0.025 1.005 - 1.087
Admission NIHSS 0.814 0.047 0.664 - 0.997
ICH – intracerebral hemorrhage, MB – micro bleeds,  
NIHSS – National Institute of Health Stroke Scale.
Discussion
The current study shows that cerebellar involvement 
is not uncommon in CAA-related ICH. Most patients 
have multiple cerebellar MBs, but some have only had 
MH involving the cerebellum in combination with MB in 
the cerebral cortex. Clinical features do not differ between 
CAA patients with or without cerebellar involvement, but 
patients with cerebellar involvement have a higher number 
of MB cortical lobar and also more often tend to have more 
intensity of white matter hyper-intensity, measured with the 
Fazekas score. 
In both patients with CAA and patients with small vessel 
disease (SVD), white matter hyperintensities (WHM) are 
seen, but the patterns of subcortical WMH are different. 
In our study age did not prove to be associated with the 
severity of white matter involvement, or with the number 
of microbleeds seen in the cerebellum. However, the finding 
that WMH are more severe in patients with cerebellar 
involvement may be used a marker of CAA-related 
leukoaraiosis or of cerebrovascular amyloid load. 
Our findings show that cerebellar involvement was 
observed in 43% of patients diagnosed with CAA based on 
the modified Boston criteria [5]. Both MB and MH were 
observed in our patients, most of the bleeding being of the 
MB type. Also, most patients with cerebellar involvement 
appear to have numerous lobar MBs (mean value of 37.8 
± 39.5) and a more severe degree of white matter hyper-
intensities, which may involve a more severe or prolonged 
course of the disease. 
The presence and number of lobar MBs as well as white 
matter burden have been associated with cognitive decline in 
patients with CAA [23]. Cognitive testing was not typically 
performed upon admission to our data sets, and therefore 
we cannot confirm this application. However, mRS scores 
at 90 days or survival do not differ between those with or 
without cerebellar involvement.
It should be noted that previous studies examining the 
pathological and radiological findings of CAA, as well as 
small vessels disease, have not examined the involvement 
of cerebellums [14, 16, 23, 24]. Brain MBs are divided into 
MBs in the lobar, which are largely secondary to CAA, and 
deep MBs, which are largely secondary to hypertension [3, 
14, 23-25]. Because the cerebellum is a relatively common 
site for hypertensive ICH, it could be speculated that 
cerebellar MB, together with WMH, may also be linked to 
chronic hypertension [11]. However, in the light of findings 
of the current study, cerebellar MB may be correlated with 
the advance of CAA, could support the hypothesis that 
WMH in CAA has a distinct pattern that may be a marker 
of amyloid load and be included in the future diagnostic 
criteria for CAA. 
For unknown reasons, CAA tends to involve the 
posterior lobes areas that are provided by the posterior 
circulation. Because the cerebellum is also provided by 
posterior circulation, similar mechanisms that are currently 
unknown may also be responsible for the involvement of the 
cerebellum in CAA.
Our study has significant limitations. First, although 
the study was based on potentially accumulated data, not 
all patients with ICH underwent MRI and the decision 
to perform or not MRI was left to the discretion of the 
neurologist who might be prejudiced. However, the 
indications and rate for MRI were similar between centers, 
as were all other patients’ characteristics. Although this can 
only reflect national preferences, in reality it reflects daily 
practices in academic centers where not all patients with 
ICH, especially those with suspected hypertensive ICH, are 
subjected to magnetic imaging.
Second, the diagnosis of CAA according to the modified 
Boston criteria is based on the presence of MRI markers. 
These criteria have high specificity, but lower sensitivity, 
because CAA can be underdiagnosed in cases where MRI 
is not performed. Third, as a registry-based cohort study, 
variations in data acquisition over time or between centers 
are possible. Finally, long-term cognitive data as well as data 
on ICH recurrence rates were not available and could have 
added value to our study, given that cerebellar involvement 
was more common in patients with a greater number of 
cortical MB.
Conclusions
Our data shows that cerebellar involvement may be 
quite common in patients with CAA, especially when 
CAA has been more advanced, as noted by the association 
with higher numbers of lobar CMB, CSS, and more severe 
white matter hyper-intensities. Cerebellar involvement 
may be present as cerebellar MH or more frequently as 
cerebellar MB in patients with lobar MH, and tends to be 
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more frequently superficial, i.e. not involving the cerebellar 
nuclei, and more often associated with a more severe form of 
white matter abnormality. Clinical presentation of patients 
with cerebellar involvement in CAA and without cerebellar 
involvement does not appear to differ. Severe white matter 
changes seen on non-contrast CT in patients with lobar or 
cerebellar hemorrhage should prompt the treating physician 
to perform MRI and to look for CAA. 
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